1. Home
  2. KTOS vs HALO Comparison

KTOS vs HALO Comparison

Compare KTOS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

HOLD

Current Price

$47.97

Market Cap

10.2B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$71.15

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTOS
HALO
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2B
8.1B
IPO Year
1999
2001

Fundamental Metrics

Financial Performance
Metric
KTOS
HALO
Price
$47.97
$71.15
Analyst Decision
Strong Buy
Buy
Analyst Count
18
11
Target Price
$96.71
$78.64
AVG Volume (30 Days)
4.3M
1.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
0.07
1.22
Revenue
$751,900,000.00
$151,862,000.00
Revenue This Year
$26.15
$28.24
Revenue Next Year
$23.43
$12.56
P/E Ratio
$735.57
$57.07
Revenue Growth
12.44
N/A
52 Week Low
$39.00
$51.06
52 Week High
$134.00
$82.22

Technical Indicators

Market Signals
Indicator
KTOS
HALO
Relative Strength Index (RSI) 32.99 57.48
Support Level N/A $67.94
Resistance Level $78.77 $71.38
Average True Range (ATR) 3.65 2.03
MACD -0.78 -0.11
Stochastic Oscillator 0.84 79.32

Price Performance

Historical Comparison
KTOS
HALO

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: